|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06887 SUNSHINE PHARMA
Nominal 
43.860 -0.040 (-0.091%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | -- | -- | 4,018,905 | 6,385,616 | 3,813,566 |
| Cost of Sales | -- | -- | (960,274) | (1,308,568) | (891,377) |
| Gross Profit | -- | -- | 3,058,631 | 5,077,048 | 2,922,189 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | -- | -- | 293 | (29) | 0 | |
| Profit / (Loss) before Taxation | -- | -- | 141,054 | 1,385,462 | (1,479,823) | |
| Taxation | -- | -- | (116,251) | (371,584) | 63,908 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | |
| Non-controlling Interests | -- | -- | (232,237) | (828,954) | 206,710 | |
| Others | -- | -- | -- | -- | 124,582 | |
| Profit / (Loss) Attributable to Shareholders | 272,442 | -- | (207,434) | 184,924 | (1,084,623) | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | -- | -- | 177,504 | 291,698 | 634,056 |
| Depreciation & Amortisation | -- | -- | 418,044 | 419,941 | 398,674 |
| Directors' Emoluments | -- | -- | 92,268 | 47,847 | 3,563 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 56.000 | -- | -47.000 | 44.000 | -329.000 |
| DPS (cts) | 0.000 | -- | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 1.135 | 3.145 | 3.521 |
| NBV per share ($) | -- | -- | 0.597 | 0.569 | (6.397) |
| Remarks: | Real time quote last updated: 02/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 272,442 |
| %Change | -- |
| EPS / (LPS) | RMB 0.560 |
| NBV Per Share (¥) | RMB -- |